Or. Admin. Code § 332-026-0010

Current through Register Vol. 63, No. 11, November 1, 2024
Section 332-026-0010 - Approved Legend Drugs For Maternal Use

An LDM may administer the following legend drugs as approved by the Board for maternal use:

(1) Anti-Hemorrhagics for use by intramuscular injection includes:
(a) Synthetic Oxytocin (Pitocin, Syntocin and generic);
(b) Methylergonovine (Methergine); or
(c) Ergonovine (Ergotrate);
(2) Anti-Hemorrhagics by intravenous infusion is limited to:
(a) Synthetic Oxytocin (Pitocin, Syntocin, and generic); or
(b) Tranexamic acid.
(3) Anti-Hemorrhagics for oral administration is limited to:
(a) Methylergonovine (Methergine);
(b) Misoprostol (Cytotec).
(4) Anti-Hemorrhagics for rectal administration is limited to Misoprostol (Cytotec).
(5) Resuscitation is limited to medical oxygen and intravenous fluid replacement.
(6) Intravenous fluid replacement includes:
(a) Lactated Ringers Solution;
(b) 0.9% Saline Solution;
(c) D5LR (5% Dextrose in Lactated Ringers); or
(d) D5W (5% Dextrose in water).
(7) Anaphylactic treatment by subcutaneous injection is limited to Epinephrine.
(8) Local anesthetic includes:
(a) Lidocaine HCl (1% and 2%) (Xylocaine and generic);
(b) Topical anesthetic;
(c) Procaine HCl (Novocain, benzocaine, cetacane and generic); and
(d) Sterile water papules.
(9) Rhesus Sensitivity Prophylaxis is limited to Rho(d) Immune Globulin (RhoGAM, Gamulin Rh, Bay Rho-D and others).
(10) Tissue adhesive (Dermabond or generic).
(11) Intravenous antibiotics for Group B Streptococcal prophylaxis is limited to the following and is only to be used solely for the purpose of Group B Streptococcal prophylaxis:
(a) Penicillin;
(b) Ampicillin;
(c) Cefazolin; or
(d) Clindamycin.

Or. Admin. Code § 332-026-0010

DEM 1-2001(Temp), f. & cert. ef. 10-1-01 thru 3-29-02; DEM 1-2002, f. 2-25-02 cert. ef. 3-1-02; DEM 1-2004, f. 6-29-04, cert. ef. 7-1-04; DEM 6-2010, f. 12-30-10, cert. ef. 1-1-11; DEM 1-2011(Temp), f. & cert. ef. 4-4-11 thru 9-27-11; Renumbered from 332-025-0040 by DEM 5-2011, f. & cert. ef. 9-26-11; DEM 2-2015, f. & cert. ef. 7/1/2015; DEM 3-2019, amend filed 12/19/2019, effective 1/1/2020; DEM 1-2023, amend filed 04/28/2023, effective 5/1/2023

Statutory/Other Authority: ORS 676.615 & ORS 687.493

Statutes/Other Implemented: ORS 687.493